Cargando…
Correction to: MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis
Autores principales: | Li, Yue, Li, You, Chen, Yao, Xie, Qian, Dong, Ningning, Gao, Yanjun, Deng, Huan, Lu, Chunhua, Wang, Suihai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894145/ https://www.ncbi.nlm.nih.gov/pubmed/29652412 http://dx.doi.org/10.1186/s12935-018-0556-5 |
Ejemplares similares
-
MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis
por: Li, Yue, et al.
Publicado: (2017) -
Correction: MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2018) -
MicroRNA-214 Inhibits Chicken Myoblasts Proliferation, Promotes Their Differentiation, and Targets the TRMT61A Gene
por: Duan, Yanjun, et al.
Publicado: (2020) -
MicroRNA-214 in Health and Disease
por: Amin, Meer M. J., et al.
Publicado: (2021) -
Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)